Royal Dsm – IL BIOECONOMISTA

The JV Reverdia will be dissolved effective 1 April 2019

22 February 201922 February 2019Il BioeconomistaLeave a comment

Effective 1 April 2019, the joint venture between Royal DSM and Roquette, Reverdia, will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium^® plant in Cassano, Italy to Roquette. Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium^®. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium^® technology, will assume the role of exclusive licensor, in line with its business model in this field.

Continue reading →

Royal DSM creates a JV with Nenter to fulfill its future need for Vitamine E

30 January 201929 January 2019Il BioeconomistaLeave a comment

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a Dutch global science-based company in Nutrition, Health and Sustainable Living, intends to create a 75/25 joint venture with Nenter & Co., Inc., which will include all Nenter’s production and related assets for Vitamin E.

Continue reading →

Tour de France: Royal DSM partners with Team Sunweb. A natural ingredient can reduce the toxic effects of exercise by more than half

9 July 20187 July 2018Il BioeconomistaLeave a comment

Royal DSM, the Dutch global science-based company in Nutrition, Health and Sustainable Living, is helping professional cyclists Team Sunweb to recover faster in this year’s Tour de France with its dietary antiplatelet, Fruitflow®. This forms part of the innovation partnership between DSM and Team Sunweb that aims to improve the health, nutrition and cycling materials of the professional athletes.

Continue reading →

DSM continues to invest in the biofuel industry

29 March 201828 March 2018Il BioeconomistaLeave a comment

Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.

Continue reading →

Eight promising bioeconomy start-ups pitched in Delft at an event organized by Royal DSM

9 October 20177 October 2017Il BioeconomistaLeave a comment

A total of eight promising start-ups were invited to pitch at the event “Connecting Bright Innovations 2017” organised by Royal DSM and held this year in Delft (Netherlands), which focused on new and innovative products and biotechnologies for food, health and (bio)tech applications. A panel of expert venturing and innovation specialists is evaluating the pitches with a view to their suitability for further financing and partnering opportunities.

Continue reading →

Royal DSM acquired Twilmij to grow in the animal feed sector

25 September 201722 September 2017Il BioeconomistaLeave a comment

A new deal in the animal feed sector. Royal DSM, the Dutch global science-based company active in health, nutrition and materials, acquired Twilmij B.V., a well-established Dutch nutritional solutions company in the animal feed sector.

Continue reading →

Amyris closes the second and final tranche of its previously announced financing

16 August 2017Il BioeconomistaLeave a comment

Amyris, the U.S. industrial bioscience company led by John Melo, closed the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25 million investment from Koninklijke DSM N.V. (Royal DSM) with the remaining $25 million contributed by Vivo Capital.

Continue reading →

Royal DSM to make an equity investment in Amyris

10 May 2017Il BioeconomistaLeave a comment

Amyris, Inc., the U.S. industrial bioscience company, and Koninklijke DSM N.V. (Royal DSM), the Dutch global science-based company active in health, nutrition and materials, have agreed for DSM to make an equity investment in Amyris. At the same time, the companies will enter into a development cooperation focused on products for the global health and nutrition markets (including vitamins and other nutritional ingredients).
Continue reading →

DSM invests in US manufactoring facility for sustainable resins

3 February 2015Il Bioeconomista1 Comment

Royal DSM, the global Life Sciences and Materials Sciences company headquartered in The Netherlands, announced yesterday a “substantial investment” in its Wilmington, Massachusetts (USA) manufacturing facility in order to produce waterborne resins for inks and coatings. Driven by its commitment to grow the sustainable coatings market, DSM will
upgrade its facilities to produce state-of-the-art waterborne resins for inks and coatings.

Continue reading →

Poet-Dsm’s Project Liberty will open its doors to the public next Wednesday

28 August 201428 August 2014Il BioeconomistaLeave a comment

Poet-Dsm’s Project Liberty will open its doors to the public at its Grand Opening celebration on Wednesday, September 3 in Emmetsburg, Iowa, showcasing first-of-its-kind technology that is poised to dramatically expand world’s resources for transportation fuel.

Continue reading →